This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages without signing in

Chemotherapy

Authoring team

Chemotherapy is indicated in two situations for the treatment of breast cancer:

  • adjuvant chemotherapy in patients at risk of micrometastasis
  • treatment of known metastatic disease

First line treatment is with an anthracycline or mitozantrone. Resistant tumours may respond to a taxol compound.

Gemcitabine in combination with paclitaxel, in cases of breast cancer who have relapsed following adjuvant/neo-adjuvant chemotherapy, is recommended as an option for the treatment of metastatic breast cancer only when docetaxel monotherapy or docetaxel plus capecitabine are also considered appropriate (1).

Reference:

  1. NICE (January 2007).Gemcitabine for the treatment of metastatic breast cancer

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.